12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
週三盤前交易時段,12只醫療保健股走勢
Gainers
獲勝者
- Heart Test Laboratories (NASDAQ:HSCS) shares rose 293.0% to $0.59 during Wednesday's pre-market session. The company's market cap stands at $6.4 million.
- Lumos Pharma (NASDAQ:LUMO) stock increased by 37.08% to $4.99. The market value of their outstanding shares is at $39.5 million. As per the news, the Q3 earnings report came out yesterday.
- Nutriband (NASDAQ:NTRB) shares increased by 20.98% to $2.71. The company's market cap stands at $21.2 million.
- Biolase (NASDAQ:BIOL) stock moved upwards by 15.18% to $1.82. The market value of their outstanding shares is at $1.8 million.
- Personalis (NASDAQ:PSNL) shares increased by 14.25% to $1.1. The company's market cap stands at $53.3 million. As per the news, the Q3 earnings report came out yesterday.
- Evolus (NASDAQ:EOLS) shares rose 13.48% to $9.17. The company's market cap stands at $522.4 million. The company's, Q3 earnings came out yesterday.
- 在週三的盤前交易中,心臟測試實驗室(納斯達克股票代碼:HSCS)股價上漲293.0%,至0.59美元。該公司的市值爲640萬美元。
- Lumos Pharma(納斯達克股票代碼:LUMO)股價上漲37.08%,至4.99美元。他們流通股的市值爲3,950萬美元。根據消息,第三季度收益報告於昨天發佈。
- Nutriband(納斯達克股票代碼:NTRB)股價上漲20.98%,至2.71美元。該公司的市值爲2,120萬美元。
- Biolase(納斯達克股票代碼:BIOL)股價上漲15.18%,至1.82美元。他們流通股的市值爲180萬美元。
- Personalis(納斯達克股票代碼:PSNL)股價上漲14.25%,至1.1美元。該公司的市值爲5,330萬美元。根據消息,第三季度收益報告於昨天發佈。
- Evolus(納斯達克股票代碼:EOLS)股價上漲13.48%,至9.17美元。該公司的市值爲5.224億美元。該公司昨天公佈了第三季度的收益。
Losers
失敗者
- Durect (NASDAQ:DRRX) stock fell 62.4% to $0.97 during Wednesday's pre-market session. The company's market cap stands at $26.7 million.
- Establishment Labs Hldgs (NASDAQ:ESTA) shares declined by 28.93% to $23.24. The company's market cap stands at $599.0 million. The company's, Q3 earnings came out yesterday.
- Tharimmune (NASDAQ:THAR) shares fell 20.81% to $0.21. The market value of their outstanding shares is at $3.6 million.
- Inspire Medical Systems (NYSE:INSP) shares fell 14.99% to $137.5. The company's market cap stands at $4.0 billion. As per the press release, Q3 earnings came out yesterday.
- Cytek Biosciences (NASDAQ:CTKB) stock decreased by 14.61% to $3.8. The company's market cap stands at $518.1 million. As per the press release, Q3 earnings came out yesterday.
- Aditxt (NASDAQ:ADTX) shares declined by 13.95% to $5.12. The market value of their outstanding shares is at $1.2 million. See Also:
- 在週三的盤前交易中,Direct(納斯達克股票代碼:DRRX)股價下跌62.4%,至0.97美元。該公司的市值爲2670萬美元。
- 建制實驗室控股公司(納斯達克股票代碼:ESTA)股價下跌28.93%,至23.24美元。該公司的市值爲5.99億美元。該公司昨天公佈了第三季度的收益。
- Tharimmune(納斯達克股票代碼:THAR)股價下跌20.81%,至0.21美元。他們流通股的市值爲360萬美元。
- Inspire Medical Systems(紐約證券交易所代碼:INSP)股價下跌14.99%,至137.5美元該公司的市值爲40億美元。根據新聞稿,第三季度業績於昨天公佈。
- Cytek Biosciences(納斯達克股票代碼:CTKB)股價下跌14.61%,至3.8美元。該公司的市值爲5.181億美元。根據新聞稿,第三季度業績於昨天公佈。
- Aditxt(納斯達克股票代碼:ADTX)股價下跌13.95%,至5.12美元。他們流通股的市值爲120萬美元。另見:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成,並由編輯審閱。